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Abstract The human leukocyte antigen (HLA) class II
genes HLA-DRB1,- DQA1 and -DQB1 are the strongest
genetic factors for type 1 diabetes (T1D). Additional loci in
the major histocompatibility complex (MHC) are difﬁcult
to identify due to the region’s high gene density and
complex linkage disequilibrium (LD). To facilitate the
association analysis, two novel algorithms were imple-
mented in this study: one for phasing the multi-allelic HLA
genotypes in trio families, and one for partitioning the
HLA strata in conditional testing. Screening and replication
were performed on two large and independent datasets: the
Wellcome Trust Case–Control Consortium (WTCCC)
dataset of 2,000 cases and 1,504 controls, and the T1D
Genetics Consortium (T1DGC) dataset of 2,300 nuclear
families. After imputation, the two datasets have 1,941
common SNPs in the MHC, of which 22 were successfully
tested and replicated based on the statistical testing strati-
fying on the detailed DRB1 and DQB1 genotypes. Further
conditional tests using the combined dataset conﬁrmed
eight novel SNP associations around 31.3 Mb on chro-
mosome 6 (rs3094663, p = 1.66 9 10
-11 and rs2523619,
p = 2.77 9 10
-10 conditional on the DR/DQ genotypes).
A subsequent LD analysis established TCF19, POU5F1,
CCHCR1 and PSORS1C1 as potential causal genes for the
observed association.
Introduction
Type 1 diabetes (T1D) is an autoimmune disease that causes
the destruction of insulin-producing b-cells of the pancreas.
Candidategenestudiesandgenome-wideassociation(GWA)
studies have identiﬁed over 40 non-HLA risk loci for T1D
(Barrett et al. 2009; Wallace et al. 2009). Still, the human
leukocyte antigen (HLA) class II genes HLA-DRB1,- DQA1
and -DQB1 remain the strongest genetic factors (Erlich et al.
2008; Koeleman et al. 2004). In particular, the haplotypes
DRB1*0401-DQA1*0301-DQB1*0302 and DRB1*0301-
DQA1*0501-DQB1*0201 confer the highest risk (OR 8.3,
p = 1.7 9 10
-42;O R6 . 6 ,p = 7.3 9 10
-23,r e s p e c t i v e l y )i n
mostpopulations,whereasDRB1*15-DQA1*01-DQB1*06is
themostprotective(OR0.0,p = 1.1 9 10
-27)inadominant
manner (Koeleman et al. 2004).
The major histocompatibility complex (MHC), home to
the HLA class II genes, is a 3.6 Mb region on chromosome
6p21.3 between ﬂanking genes MOG (telomeric) and
COL11A2 (centromeric). The region is essential to the
immune system, and is known to harbor an exceptionally
high density of 224 gene loci (Horton et al. 2004). Some of
those genes and certain regions in the extended MHC,
which includes also 3.9 Mb telomeric and 0.2 Mb centro-
meric extensions, have been identiﬁed to be involved in the
etiology of T1D (Table 1). Although the MHC is generally
believed to harbor additional T1D-associated genes, the
overshadowing effect of the HLA class II genes and the
strong and complicated linkage disequilibrium (LD) within
that region (Alper et al. 2006; de Bakker et al. 2006) make
such associations hard to uncover by conventional metho-
dologies. The high polymorphism of DRB1 (762 alleles),
DQA1 (35 alleles) and DQB1 (107 alleles) (EMBL-EBI
2010), and the complex interactions of genes in the region
further complicate the problem.
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123There are a handful of statistical techniques for studying
the association of markers conditional on certain primary
factors (Thomson et al. 2008), to account for any effects
due to LD with those factors. One major branch of con-
ditional testing strategies is the stratiﬁcation approach.
Some methods in this family require careful selection of
cases and controls that match speciﬁc genotypes under
consideration. These include matched genotype strategies
(Haniﬁ Moghaddam et al. 1998), and the homozygous
parent linkage method (HPLM) for affected sib pairs
(Robinson et al. 1993) and the homozygous parent trans-
mission disequilibrium test (HPTDT) (Johansson et al.
2003; Lie et al. 1999; Santin et al. 2009; Viken et al. 2009)
for trios. The major drawback of the approach is the
reduction in samples available for analysis. Alternative
stratiﬁcation-based methods that use all samples without
imposing stringent selection criteria include the conditional
haplotype method (CHM), the conditional genotype
method (CGM) and the conditional extended transmission
disequilibrium test (CETDT) (Cucca et al. 2001; Koeleman
et al. 2000a, b). The basic assumption of these three
methods is that for no association, the relative allele fre-
quencies of the test locus should be the same in cases and
controls in each stratum of primary haplotype or genotype.
Both CHM and CETDT, however, require the inference of
haplotype phase. As extensions to CHM and CGM, the
overall conditional haplotype method (OCHM) (Thomson
1984) and the overall conditional genotype method
(OCGM) (Valdes et al. 2009) deﬁne a test statistic that
measure the additional genetic effect summed over all
haplotype or genotype strata. Besides stratiﬁcation, other
conditional testing techniques include conditional logistic
regression (CLR) (Eike et al. 2009a; Howson et al. 2009;
Nejentsev et al. 2007) and LD-adjusted association tests
(Cruz et al. 2004; Noble et al. 2002; Valdes et al. 2005).
In this study, we applied conditional tests on each single
nucleotide polymorphism (SNP), stratiﬁed by the DR/DQ
alleles in a manner similar to the OCHM and OCGM
methods described above. The effects of individual SNPs
in addition to the DR/DQ genotypes are measured by their
respective overall p values obtained through stratiﬁed
analysis, which does not assume any particular model or
involve any likelihood estimations. Thus, the results were
expected to be more reliable (Huang 1999). This study was
carried out in two stages: an initial screening stage and a
replication stage that veriﬁes the associations of the sig-
niﬁcant SNPs emerged from the screening. First, the case–
control dataset from the Wellcome Trust Case–Control
Consortium (WTCCC) (WTCCC 2007) was used for
screening followed by replication based on an independent
trio dataset from the T1D Genetics Consortium (T1DGC)
(Brown et al. 2009). Then, the same two-stage procedure
was repeated with the roles of the two datasets switched.
T
a
b
l
e
1
c
o
n
t
i
n
u
e
d
M
H
C
r
e
g
i
o
n
L
o
c
i
P
o
s
i
t
i
o
n
(
M
b
)
R
e
f
e
r
e
n
c
e
s
E
v
i
d
e
n
c
e
f
o
r
a
s
s
o
c
i
a
t
i
o
n
S
u
b
j
e
c
t
s
a
n
d
m
e
t
h
o
d
s
o
f
a
n
a
l
y
s
e
s
H
L
A
-
G
2
9
.
9
1
E
i
k
e
e
t
a
l
.
(
2
0
0
9
a
)
S
N
P
s
r
s
4
1
2
2
1
9
8
(
p
=
1
.
5
9
1
0
-
8
)
,
r
s
2
3
9
4
1
8
6
(
p
=
2
.
1
9
1
0
-
8
)
,
r
s
1
6
1
9
3
7
9
(
p
=
1
.
1
9
1
0
-
7
)
a
n
d
r
s
1
6
1
1
1
3
3
(
p
=
3
.
2
9
1
0
-
6
)
L
R
c
o
n
t
r
o
l
l
e
d
f
o
r
D
R
-
D
Q
:
2
,
3
2
1
f
a
m
i
l
i
e
s
(
T
1
D
G
C
)
B
e
t
w
e
e
n
U
B
D
a
n
d
M
A
S
1
L
2
9
.
6
3
–
2
9
.
5
6
A
l
y
e
t
a
l
.
(
2
0
0
8
)
S
N
P
r
s
1
2
3
3
4
7
8
(
p
=
1
.
4
9
1
0
-
1
2
a
f
t
e
r
c
h
r
o
m
o
s
o
m
e
s
w
i
t
h
t
h
e
h
i
g
h
l
y
c
o
n
s
e
r
v
e
d
M
H
C
8
.
1
h
a
p
l
o
t
y
p
e
w
e
r
e
r
e
m
o
v
e
d
)
A
F
B
A
C
:
2
3
7
f
a
m
i
l
i
e
s
f
r
o
m
U
S
;
1
,
2
4
0
f
a
m
i
l
i
e
s
f
r
o
m
U
K
,
U
S
a
n
d
D
e
n
m
a
r
k
(
T
1
D
G
C
)
f
o
r
r
e
p
l
i
c
a
t
i
o
n
E
x
t
e
n
d
e
d
C
l
a
s
s
I
T
e
l
o
m
e
r
i
c
o
f
H
L
A
-
F
2
7
.
7
7
L
i
e
e
t
a
l
.
(
1
9
9
9
)
M
i
c
r
o
s
a
t
e
l
l
i
t
e
D
6
S
2
2
2
3
*
3
(
p
=
0
.
0
0
0
0
4
)
p
r
o
t
e
c
t
i
v
e
H
o
m
o
z
y
g
o
u
s
p
a
r
e
n
t
T
D
T
(
H
P
T
D
T
)
o
n
D
R
B
1
*
0
3
-
D
Q
A
1
*
0
5
0
1
-
D
Q
B
1
*
0
2
0
1
:
1
1
6
f
a
m
i
l
i
e
s
f
r
o
m
N
o
r
w
a
y
,
D
e
n
m
a
r
k
a
n
d
U
K
J
o
h
a
n
s
s
o
n
e
t
a
l
.
(
2
0
0
3
)
D
6
S
2
2
2
3
*
3
(
p
=
0
.
0
3
)
p
r
o
t
e
c
t
i
v
e
H
P
T
D
T
o
n
D
R
B
1
*
0
3
-
D
Q
A
1
*
0
5
0
1
-
D
Q
B
1
*
0
3
0
1
:
4
3
f
a
m
i
l
i
e
s
f
r
o
m
S
w
e
d
e
n
a
n
d
S
o
u
t
h
e
r
n
F
r
a
n
c
e
S
a
n
t
i
n
e
t
a
l
.
(
2
0
0
9
)
D
6
S
2
2
2
3
*
3
(
p
=
0
.
0
0
1
)
p
r
o
t
e
c
t
i
v
e
H
P
T
D
T
o
n
D
R
B
1
*
0
3
-
D
Q
A
1
*
0
5
0
1
-
D
Q
B
1
*
0
2
0
1
:
1
1
1
C
a
u
c
a
s
i
a
n
p
a
r
e
n
t
s
P
R
S
S
1
6
2
7
.
3
3
S
a
n
t
i
n
e
t
a
l
.
(
2
0
0
9
)
S
N
P
s
r
s
6
9
3
1
7
1
1
,
r
s
8
5
8
9
8
8
,
r
s
9
3
6
8
4
9
2
,
r
s
9
3
9
3
7
9
6
,
r
s
9
3
4
8
7
5
6
,
r
s
9
3
6
8
4
9
3
a
n
d
r
s
6
9
3
8
3
9
7
(
p
=
0
.
0
2
,
a
l
l
S
N
P
s
i
n
p
e
r
f
e
c
t
L
D
)
H
P
T
D
T
o
n
D
R
B
1
*
0
4
0
1
-
D
Q
A
1
*
0
3
-
D
Q
B
1
*
0
3
0
2
:
6
2
C
a
u
c
a
s
i
a
n
p
a
r
e
n
t
s
B
T
N
3
A
2
2
6
.
4
8
V
i
k
e
n
e
t
a
l
.
(
2
0
0
9
)
S
N
P
r
s
9
3
7
9
8
5
7
(
p
=
0
.
0
1
)
H
P
T
D
T
o
n
D
R
B
1
*
0
3
-
D
Q
A
1
*
0
5
0
1
-
D
Q
B
1
*
0
2
0
1
:
1
1
1
C
a
u
c
a
s
i
a
n
p
a
r
e
n
t
s
Hum Genet (2011) 129:161–176 163
123LD analysis was next performed on the replicated SNPs,
and the novelty of each locus was established through
conditional tests that adjust, respectively, for the HLA-A,
-B,- C and -DPB1 genes, in addition to the DR/DQ geno-
types. Finally, the possible causal genes were located if
they have one or more SNPs, preferably non-synonymous
ones, in reasonably strong LD with any of the SNPs with
novel associations. A summary of our analytical plan is
shown in Fig. 1. A T1D locus in the MHC class I region
was identiﬁed by our two-stage study.
Results
Data preparation
The WTCCC dataset consists of 2,000 T1D cases and
1,504 controls, all from the British population. Samples
were genotyped on the Affymetrix500K platform, with
1,312 SNPs across the MHC, of which 330 were also in the
T1DGC dataset. Genotype information is available for ﬁve
HLA loci: HLA-A,- B,- C,- DRB1 and -DQB1. Owing to the
small number of common SNPs in the two datasets,
imputation of genotypes was necessary using the CEU
HapMap (The International HapMap Consortium 2005)
samples as a reference. After imputation and imposing
quality control by excluding SNPs with minor allele fre-
quency (MAF) \0.01 or Hardy–Weinberg equilibrium
(HWE) p value below the Bonferroni’s-corrected 5% sig-
niﬁcance level, the dataset was expanded to 9,370 SNPs in
the MHC.
The T1DGC MHC Fine Mapping Project is targeted at
providing a dense SNP map to ensure comprehensive
coverage in the MHC region. When compared with the
WTCCC, the T1DGC dataset has a higher SNP density in
the MHC. It includes 2,300 nuclear families with 9,749
individuals from nine cohorts, mainly of Caucasian eth-
nicity. It consists of genotypes for 2,957 SNPs as well as
eight HLA genes, namely HLA-A,- B,- C,- DPA1,- DPB1,
-DRB1,- DQA1 and -DQB1, in the classical MHC. Any
Mendelian errors were set as missing values. Then, SNPs
with MAF\0.01 or call rate \0.95 were removed, and
the remaining SNPs were tested for HWE at 5% signiﬁ-
cance level after Bonferroni’s correction, leaving a total of
2,259 SNPs. To avoid any inﬂation of test statistics that
could be introduced by population structure, 281 samples
of non-European origin were discarded, leaving behind
2,240 families. Families without any affected child (15) or
with parental genotypes missing (550) were then removed.
This led to 1,675 trio families that have genotypes for both
Fig. 1 Summary of analytical plan. a Processing of WTCCC dataset. b Processing of T1DGC dataset. c Procedures of statistical and LD
analyses
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123parents and at least one affected child. It is worth noting
that parents of affected or unknown T1D status were kept
at this point so that their affected child and unaffected
spouse could be properly phased. In families with more
than one affected child, the one with the lowest count of
missing genotypes was selected. Using the affected family-
based controls (AFBAC) approach (Thomson 1995), both
the SNP and HLA genotypes of each trio were transformed
into a case and a pseudo-control, which is composed of the
non-transmitted alleles from the parents. Trio phasing and
imputation of the SNP genotypes were performed by
Beagle v.3.0 (Browning and Browning 2009). The multi-
allelic HLA genotypes were phased by a novel algorithm.
Details of the algorithm are discussed in the ‘‘Materials and
methods’’. After removing 146 and 971 haplotypes of
pseudo-controls, respectively, from parents of affected and
unknown T1D status, we arrived at a dataset of 3,350 and
2,233 phased case and control haplotypes, respectively,
with a coverage of 2,259 SNPs in the MHC.
Screening and replication study conditional on DR/DQ
We ﬁrst used the WTCCC dataset for initial screening.
With phases unknown, we applied the Cochran–Armitage
(CA) trend test (Armitage 1955; Freidlin et al. 2002)o n
SNP genotypes with subjects stratiﬁed by their DRB1 and
DQB1 genotypes. By assuming a co-dominant mode of
inheritance for the trend test, the dosage effect of an allele
can be accounted. As DQA1 is in strong LD with DRB1 and
DQB1, it is sufﬁcient to condition only on the two genes
when the typing of DQA1 is unavailable. This subject-
based approach of stratiﬁcation, similar to OCGM, has the
advantage of capturing both the cis- and trans-effect of the
tested loci on the DR/DQ genotypes. When compared with
the conventional logistic regression technique for condi-
tional analysis, which involves maximum likelihood esti-
mations of multiple parameters, obtaining p values by
exact conditional tests based on the stratiﬁcation is a more
direct approach to identify the positions of associated loci
in the gene-dense MHC region with complicated LD. In
this stage, only the 1,941 SNPs common to both dataset
were tested. Out of these, 114 SNPs passed the two-tailed
tests at 5% signiﬁcance level with Bonferroni’s correction
(p\0.05/1941 & 2.58 9 10
-5).
In the next stage, a replication study was done using the
T1DGC dataset. With haplotype phases inferred from the
trio data, the Mantel–Haenszel (MH) test (Mantel and
Haenszel 1959; Yu and Schaid 2007) was applied on each
SNP by counting the number of transmitted and non-
transmitted alleles stratiﬁed by their DRB1-DQA1-DQB1
haplotypes. The MH test has the advantage of being more
sensitive when the effects across strata are generally in the
same direction. The approach is similar in concept to
OCHM, which tests for an additional effect over all hap-
lotypes, in this case, the DR/DQ haplotypes. Haplotype-
based matching is more speciﬁc at ruling out any effect due
to LD on the same chromosome than the subject-based
approach which stratiﬁes on genotypes. Of the 114 SNPs
which passed the initial screening, 15 were successfully
replicated based on the false discovery rate (FDR)
approach (Benjamini and Hochberg 1995)( p\15 9 0.05/
114 & 6.58 9 10
-3).
To capture those SNPs showing stronger associations in
the T1DGC dataset than in the WTCCC dataset, the con-
ditional analysis was carried out again with the roles of the
two datasets switched: T1DGC dataset for initial screening
and WTCCC dataset for replication. Out of the 1,941
common SNPs under test, 29 were able to pass the
Bonferroni’s-corrected 5% signiﬁcance level, of which 7
were successfully replicated at 5% FDR (p\7 9 0.05/
29 & 0.0121). It was expected that a fewer number of
SNPs passed the screening, since the T1DGC dataset is
smaller in size and hence less powerful statistically. The
seven newly replicated SNPs were all different from the 15
obtained in the previous round of analysis, making a total
of 22 replicated SNPs. These SNPs, together with their
conditional p values for the two datasets, are listed in
Table 2. Plots of the conditional p values of all SNPs with
respect to their chromosome positions are shown in Figs. 2
and 3, respectively, for the two datasets.
LD analysis was performed on the replicated SNPs
using Haploview (Barrett et al. 2005) based on the CEU
HapMap Phase II haplotypes (Fig. 4). Four LD blocks were
identiﬁed by the conﬁdence interval method (Gabriel et al.
2002) using the default settings, i.e. a block is created if
95% of informative comparisons are strong LD, with the
upper and lower 95% conﬁdence bounds for D0 [0.98
and[0.7, respectively.
Further conditional analysis adjusted
for HLA-A,- B,- C and -DPB1
To verify whether the associations of any of these loci were
the results of LD with some known T1D-associated HLA
genes in their neighborhood, more conditional tests were
applied. This was done by including the gene to be con-
trolled for as a stratiﬁcation factor in addition to the DRB1
and DQB1 genes in the CA trend test. The ﬁve replicated
SNPs within 200 kb from HLA-A were tested for T1D
association conditional on the HLA-A,- DQB1 and -DRB1
genotypes. Likewise, tests on Blocks 1–3, rs2844621 and
rs2523619 were controlled for HLA-B and -C, and tests on
Block 4 and rs2281390 controlled for HLA-DPB1 and
-DPA1, due to their proximities with the respective genes
on the chromosome. If the p value of the tested locus then
becomes insigniﬁcant, we can conclude that it is in LD
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123with one or more alleles of the additional stratifying gene
which exhibit similar confounding effects on the DR/DQ
genotypes.
In general, the overall statistical power of the tests
decreases with the introduction of an additional stratiﬁca-
tion factor due to a fewer number of samples in each
Fig. 2 p values of the WTCCC
dataset conditional on the HLA-
DRB1-DQB1 genotypes based
on the stratiﬁed Cochran-
Armitage trend test. The
classical MHC subregions and
some relevant genes are
included for reference. Position
is along chromosome 6, NCBI
genome build 36.3
Fig. 3 p values of the T1DGC
dataset conditional on the HLA-
DRB1-DQA1-DQB1 haplotypes
based on Mantel–Haenszel test.
The classical MHC subregions
and some relevant genes are
included for reference. Position
is along chromosome 6, NCBI
genome build 36.3
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123stratum. Therefore, we used all samples combined from the
two datasets when adjusting for the HLA-A,- B and
-C genotypes in the conditional analysis based on the CA
trend test. However, since the genotypes of DPB1 and
DPA1 are not available in the WTCCC dataset, we could
only apply the MH test on the T1DGC dataset to control for
the two genes. By counting the number of haplotypes, the
approach can help in improving the statistical power, but it
is also prone to underestimate the trans-effect of an SNP on
the confounding haplotype, leading to more conservative
results in general.
The combined dataset has a total of 4,225 cases and
2,771 controls. Apart from the 3,675 cases and 2,620
controls previously utilized in screening and replication, it
includes an additional 550 cases and 151 controls with
unknown haplotype phases. These samples come from
families in the T1DGC dataset with parental genotypes
missing, and at most one affected and one unaffected sib-
lings were taken from each family (Curtis 1997). In com-
bining the two datasets, the alleles of all common SNPs
were made consistent based on their strand orientation
information. HLA genotypes of high resolution were pre-
ferred, but those of low resolution were also used.
To further enhance the statistical power, we imple-
mented a partitioning algorithm that reduces the number of
HLA strata without compromising the confounding effects
of the factors. For each unique stratum, the algorithm
progressively grows a subset of the HLA alleles until there
is not a remaining allele in the stratum that can exert an
additional effect of p\0.5. The consolidated set of alleles
is then adopted as the new stratum. The conservative
choice of p\0.5 is to ensure that even any weak effects of
the stratiﬁcation factors are retained after the partitioning
process. For instance, there are altogether 4,011 strata for
the HLA-DRB1,- DQB1 and -A genotypes, resulting in an
effective sample size of 1,133 cases and 453 controls, after
those strata consisting of all controls or all cases were
eliminated. Our partitioning algorithm reduces the number
of strata to 1,408 and hence increases the effective sample
size to 2,302 cases and 745 controls.
After controlling for the HLA-DRB1-DQB1-A geno-
types, the ﬁve replicated SNPs near HLA-A became insig-
niﬁcant, indicating their effects were mostly due to LD with
the gene. Similarly, Blocks 1–3 and SNPs rs2844621 and
rs2523619 were tested for association conditional, respec-
tively, on the HLA-DRB1-DQB1-B and HLA-DRB1-DQB1-
C genotypes. With ﬁve independent loci under test, the 5%
signiﬁcance level with LD-adjusted Bonferroni’s correction
(Duggal et al. 2008) becomes 0.05/5 or 0.01. Of the 11
replicated SNPs under investigation, SNPs rs3094663 from
Fig. 4 LD between the 22 replicated SNPs. The ﬁgure in each box
givestheﬁrsttwodecimalplacesofther
2value.LDblocksidentiﬁedby
theconﬁdenceintervalmethodwereoutlined.IDsinblueindicateSNPs
thatpassscreeningwithWTCCCdataset,whereasIDsingreenindicate
SNPsthatpassscreeningwithT1DGCdataset.AllSNPsshowingnovel
associations are highlighted in bold (color ﬁgure online)
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123Block 1, rs7381988 from Block 3 and rs2523619 were able
to pass both conditional tests with p\0.01. If the 5% FDR
was adopted instead, seven more SNPs could pass both
tests, with two of them from Block 2. The results show that
Blocks 1–3 and SNP rs2523619 harbor additional effects on
T1D not due to LD with HLA-B and -C. Finally, conditional
tests stratiﬁed, respectively by the HLA-DRB1-DQB1-
DPB1 and HLA-DRB1-DQB1-DPA1 genotypes were per-
formed on Block 4 and SNP rs2281390. While Block 4 was
disproved after adjusting also for DPB1, rs2281390 was
able to pass the tests with p\0.05/2 = 0.025. p values of
the conditional tests are summarized in Table 3.
The p values of all SNPs conditional on the different
HLA genes were plotted in Figs. 5a–d. In Fig. 5a, the
stratiﬁcation on HLA-A almost completely nulliﬁed all SNP
associations in the neighborhood, while the associations of
SNPs farther away remained prominent. This proves the
robustness and effectiveness of our partitioning algorithm
in reducing the number of HLA strata while retaining most
of their confounding effects. Upon conditioning on HLA-B,
the associations of rs2523619 and rs3094663 were more
outstanding than other replicated SNPs in that region.
A considerable level of LD was observed between Block 4
and HLA-B, even though they are about 1.8 Mb apart. In
particular, the association of rs2281390 was totally gone
after conditioning on HLA-B. Therefore, the SNP was not
considered a novel association, despite its passing of the
tests conditioned on HLA-DPB1 and -DPA1. When com-
pared with HLA-B, conditioning on HLA-C had smaller
impact on the p values and the LD with HLA-DPB1 was
seemingly conﬁned to a shorter range.
p values and odds ratios (OR) of each novel SNP
association in individual HLA haplotype strata are avail-
able in Supplementary Tables 2–7. The statistics were
obtained by applying the Fisher’s exact test on the number
of major and minor alleles on each HLA haplotype based
on the phased T1DGC dataset. For example, with regard to
DRB1-DQB1-DQA1, rs2523619 has p = 0.011 and OR 0.3
and OR 0.43, respectively, for the DRB1*802-DQB1*402-
DQA1*401 and DRB1*101-DQB1*501-DQA1*101 haplo-
types. If HLA-C is taken into consideration as well, we
found that the effect of the SNP is particularly strong on
C*702, with p = 0.0002, OR 0.07 and p = 0.0264, OR
0.08, respectively, for the DRB1*101-DQB1*501-C*702
and DRB1*802-DQB1*402-C*702 haplotypes. The minor
allele of the SNP also tends to exhibit susceptibility across
strata.
Locating causal genes through detailed LD analysis
To further track down the causal genes, detailed LD
analysis was carried out and the results were summarized
in Supplementary Table 1. Of the ten novel SNP
associations, rs2394953 and rs7382297 were in perfect LD
(r
2 = 1) with rs3130542 and rs3132499, respectively, and
can thus be excluded. For the remaining eight SNPs, we
examined their LD with SNPs residing in the functional
areas of some nearby genes. A list of gene-afﬁliated SNPs
was retrieved through NCBI Entrez.
The 30.7–32 Mb region on chromosome 6 was consid-
ered. The range was chosen to encompass the SNPs under
study with ﬂanking margins of 500 kb. Of the over 10,000
SNPs obtained, only a small fraction was available in the
CEU HapMap haplotypes. After removing the redundant
SNPs, i.e. those from the same gene and in perfect LD, we
Table 3 p values of replicated SNPs conditional on nearby T1D-
associated HLA genes in addition to DRB1 and DQB1
Block SNP ID SNP Pos p
CA trend test conditional on
a: DR-DQ-A
rs1619379 29893214 0.4107
rs3873283 30040979 0.5397
rs379221 30058119 0.1085
rs916570 30174010 0.4594
rs1116221 30179309 0.4687
Block SNP ID SNP Pos p
CA trend test conditional on
a: DR-DQ-BD R -DQ-C
1 rs3094663
b 31215066 3.18 9 10
-3b 2.57 9 10
-3b
rs3130503
c 31245144 0.0199
c 0.0120
rs3094609
c 31273545 0.0246
c 3.13 9 10
-3b
rs3134782
c 31305612 0.0259
c 2.52 9 10
-3b
rs3132499
c 31315899 0.0388
c 5.88 9 10
-3b
2 rs3130542
c 31340090 7.68 9 10
-3b 0.0135
c
rs2394953
c 31341332 0.0107
c 0.0217
c
rs2844621 31349516 7.05 9 10
-3b 0.0515
c
3 rs7381988
b 31354682 9.84 9 10
-3b 2.36 9 10
-3b
rs7382297
c 31355046 0.0480
c 7.69 9 10
-3b
rs2523619
b 31426123 5.74 9 10
-4 3.21 9 10
-5b
Block SNP ID SNP Pos p
MH test conditional on
d DR-DQ-DPB1 DR-DQ-DPA1
4 rs2281390 33167647 0.0108
b 3.08 9 10
-3b
rs6457721 33215729 0.3820 4.12 9 10
-8
rs721394 33225796 0.2711 1.20 9 10
-8
rs9380350 33234843 0.2349 9.80 9 10
-9
rs9368757 33236355 0.2741 8.86 9 10
-9
rs9380351 33237724 0.2937 1.11 9 10
-8
a Using combined dataset of 4,225 cases and 2,771 controls
b SNPs or p values that pass the LD-adjusted 5% Bonferroni’s sig-
niﬁcance level. SNPs showing novel associations are highlighted in
bold
c SNPs or p values that pass the 5% FDR criterion
d Using T1DGC dataset of 3,350 case and 2,233 control haplotypes
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123had 115 non-synonymous and 502 synonymous SNPs,
covering about 50 and 84% of the genes in that region.
For the 7 SNPs in Blocks 1–3, rs2073721 of gene TCF19
(31.237 Mb) emerged consistently as the one showing the
strongest LD (in terms of r
2) among all the non-synony-
mous SNPs, despite the fact that two of the SNPs in Block 1,
rs3094663 and rs3130503, are in the introns of PSORS1C1
(31.2 Mb) and POU5F1 (31.243 Mb). In particular,
D0 = 0.959 and r
2 = 0.818 between rs3094663 and
rs2073721, and D0 = 1 and r
2 = 0.848 between rs3130503
and rs2073721. In addition, synonymous SNPs rs1065461
and rs2073722 of TCF19 showed moderate to strong LD
with the SNPs in Blocks 1–3, with r
2 ranging from 0.59 to 1
proving further the relevance of the gene.
Apart from TCF19, POU5F1 and CCHCR1 (31.22 Mb)
also have several SNPs in considerable LD with Blocks
1–3. For instance, the non-synonymous SNP rs3130932 in
POU5F1 has D0 = 1 and r
2 = 0.675 with rs3130503. For
CCHCR1, two non-synonymous SNPs, rs130066 and
rs3130453, have, respectively, an LD of D0 = 1, r
2 = 0.28
and D0 = 1, r
2 = 0.31 with rs3130503.
Replicated SNP rs2523619 has weak LD (r
2\0.3) with
all the non-synonymous SNPs in the region. Nevertheless,
among the ten synonymous SNPs having the strongest LD
with rs2523619, six were from PSORS1C1, of which three
were at the top and the highest LD being D0 = 0.753 and
r
2 = 0.478 with rs3815087. The LD between the eight
replicated SNPs with novel associations and the missense
SNPs in three of the genes were shown in Fig. 6a–c. The
risk alleles of the replicated SNPs in Blocks 1–3, which
happened to be all minor alleles, are consistently in
stronger LD with the major alleles of the missense SNPs of
Fig. 5 p values conditional on HLA-DRB1-DQB1 together with
HLA- a A, b B, c C and d DPB1, respectively. p values of a–c are
generated by applying stratiﬁed Cochran–Armitage trend test on the
combined dataset, whereas p values in d are generated by applying
Mantel–Haenszel test on the phased T1DGC haplotypes. Signiﬁcance
levels were indicated in the appropriate regions under test. The
classical MHC subregions and some relevant genes are included for
reference. Position is along chromosome 6, NCBI genome build 36.3
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123the four genes under study. However, the risk allele of
rs2523619 does not always map to the same missense allele
as the other replicated SNPs. It is only in unison with others
for PSORS1C1.
The effects of the missense alleles on the amino acids
and their side chain properties, which may in turn inﬂuence
the protein structures, are summarized in Table 4. The
results of LD analysis hint at the potential roles of TCF19,
POU5F1, CCHCR1 and PSORS1C1 in the etiology of
T1D, with TCF19 supported by the strongest r
2 measure.
Discussion
TCF19 (Transcription Factor 19, previously known as SC1)
is a late growth-regulated gene with a putative amino acid
sequence that bears the characteristics of a trans-activating
factor; hence, implying its role in the regulation of
expression of other genes necessary for the later stages of
cell cycle progression (Ku et al. 1991). TCF19 is one of the
transcription factors involved in cell proliferation or dif-
ferentiation being up-regulated in human pro-B and pre-B
cells (Hystad et al. 2007). It is also highly expressed in
germinal center cells. A non-synonymous SNP in TCF19,
rs7750641, was found to be associated with lymphocyte
count, mean cell hemoglobin, white blood cell count,
hematocrit count, and eosinophil count (p = 2.3 9 10
-7)
in a multivariate analysis (Ferreira et al. 2009). Although
the cause is largely unknown, there is evidence that the
destruction of islet b-cells in T1D is the result of a disorder
of immunoregulation: islet b-cell autoreactive T cells
dominate over protective regulatory T cells, which develop
inadequately due to some genetic or environmental factors.
TCF19 may be one of the key players in maintaining such
immunological balance.
POU5F1 (POU class 5 Homeobox 1, also known as
OCT3 or OCT4) encodes a transcription factor containing a
POU homeodomain. This transcription factor is involved in
the embryonic development, especially during early
embryogenesis, and is necessary for embryonic stem cell
pluripotency. It is also essential for endoderm formation
(Lunde et al. 2004), which is a precursor to pancreas
development. Speciﬁcally, the gene is found to be
expressed in pancreatic endocrine progenitor cells.
CCHCR1 (coiled-coil alpha-helical rod protein 1, for-
merly known as HCR), a plausible candidate gene for
psoriasis (Asumalahti et al. 2002), was shown to promote
steroidogenesis by interacting with the steroidogenic acute
regulator protein (StAR) (Sugawara et al. 2003). The pro-
tein is abundantly expressed in heart, liver, skeletal muscle,
kidney and pancreas. Steroid hormones mediate various
vital physiological functions, such as the regulation of
metabolism and immune response. In some T1D patients,
Fig. 6 LD between the eight replicated SNPs with novel T1D
associations and the missense SNPs within a TCF19, b CCHCR1 and
c PSORS1C1. Only SNPs available in the CEU HapMap dataset were
studied and any redundant SNPs were removed. All missense SNPs
are highlighted in bold and red. Boxes of D0 = 1 are outlined in
yellow (color ﬁgure online)
Hum Genet (2011) 129:161–176 171
123steroids appear to lower the number of islet cell antibodies
and prolong the time between the development of the
antibodies and the onset of symptoms. On the other hand,
steroids can increase insulin resistance in liver and skeletal
muscle, thus reducing glucose uptake in cells. The changes
in the insulin sensitivity are known to have impact on the
T1D process (Greenbaum 2002).
Two synonymous SNPs in exon 2 of PSORS1C1 (pso-
riasis susceptibility 1 candidate 1, earlier known as
SEEK1) were reported to be associated with psoriasis in
the Swedish population even upon stratiﬁcation for the
predisposing HLA-Cw*0602 allele (Holm et al. 2003). The
gene has two protein isoforms, and is expressed in pancreas
and kidney among other tissues. However, the function of
the protein in biological processes remains largely
unknown. The two missense SNPs, rs1265097 and
rs9501057, in complete LD (D0 = 1) with all the eight
novel SNP associations, are both located in exon 5 of
PSORS1C1, which is translated in both isoforms.
In summary, we performed a detailed stratiﬁed analysis
in search of additional T1D loci in the MHC using the large
and independent WTCCC and T1DGC datasets. To faci-
litate the analysis, two novel algorithms were implemented:
one for phasing the multi-allelic HLA genotypes in trio
families, and the other one for partitioning the HLA strata,
while retaining their confounding effects in conditional
testing, with the goal to enhance the statistical power. When
compared with the likelihood-based approaches, our pro-
posed model-free approach can more accurately determine
the strength of association of each SNP over other potential
factors, and is computationally feasible for large datasets.
Therefore, we believe it is a promising framework for future
conditional analyses in the MHC. Our study has identiﬁed
eight novel SNP associations which established the evi-
dence for an additional T1D locus in the MHC class I region
at around 31.3 Mb on chromosome 6. Detailed LD analysis
has singled out four potential causal genes responsible for
the observed SNP associations. They include TCF19,
POU5F1, CCHCR1 and PSORS1C1, all within a 56 kb
region. Owing to high gene density and complicated LD,
further ﬁne mapping and analyses are necessary for pin-
pointing the exact causal polymorphism in that region.
Materials and methods
Wellcome Trust Case–Control Consortium (WTCCC)
genotype dataset for initial screening
The dataset has 2,000 T1D cases and 1,504 controls (from
the 1958 British Birth Cohort). All samples are from the
British population and genotyped on the Affymetrix500K
platform. HLA typing information is available for ﬁve loci:
HLA-A,- B,- C,- DRB1 and -DQB1. To improve SNP
density in the MHC, the IMPUTE (Howie et al. 2009)
software was run on the dataset based on the CEU HapMap
(The International HapMap Consortium 2005) haplotypes
with ancestry from northern to western Europe, expanding
the coverage to 9,878 SNPs and at the same time inferring
any missing genotypes. The threshold for calling genotypes
in IMPUTE was set to be 0.9, i.e. for each SNP of each
individual, the genotype will be treated as missing if the
maximum genotype probability is \0.9. Furthermore,
SNPs with MAF\0.01 in all samples or p\0.05/
Table 4 Protein-coding information for selected missense SNPs of TCF19, POU5F1, CCHCR1 and PSORS1C1
Gene No. of
exons
No. of
isoforms
Missense SNP Allele
change
a
Residue
change
Residue polarity
and charge change
ID Position Exon No.
TCF19 4 2 rs7750641 31237289 3 C?TP ?Sn p ?p
rs2073721 31237595 3 G?AV ?Mn p ?np
rs2073724 31237686 3 C?TP ?Ln p ?np
POU5F1 4 6 rs3130932 31241922 1 G?TR ?Mp ??np
CCHCR1 18 14 rs1576 31218370 18 C?GS ?Cp ?np
rs130067 31226490 6 A?CE ?Dp -?p-
rs130066 31230294 4 C?GS ?Rp ?p?
rs130076 31230461 4 C?TR ?Wp ??np
rs3130453 31232828 2 C?TW ?Xn p ?(N/A)
PSORS1C1 6 2 rs1265097 31214438 5 G?TP ?Tn p ?p
rs9263726 31214478 5 G?AR ?Hp ??p?
rs9501057 31214495 5 C?TP ?Sn p ?p
rs1063646 31215627 6 C?TP ?Ln p ?np
Abbreviations for amino acid side chain properties: p polar, np, non-polar; ?, positively charged; -, negatively charged
a From major to minor alleles
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1239878 & 5.06 9 10
-6 for HWE tests in the controls were
excluded, resulting in a total of 9,370 SNPs. Information on
the access to the WTCCC T1D dataset is available at http://
www.wtccc.org.uk/info/access_to_data_samples.shtml.
Type 1 diabetes genetics consortium (T1DGC)
genotype dataset for replication study
The dataset consists of 2,300 trio families with 9,749
individuals from 9 cohorts; namely, Asia Paciﬁc (AP; 191),
British Diabetic Association (BDA; 418), Danish (DAN;
147), European (EUR; 475), Human Biological Data
Interchange (HBDI; 431), Joslin Diabetes Center (JOS;
112), North American (NA; 334), Sardinian (SAR; 78) and
United Kingdom (UK; 114). Based on the primary, sec-
ondary and tertiary ethnic groups of each subject, 281
individuals of non-European origin from 80 families (AP:
21; EUR: 14; NA: 40; UK: 5) were removed, to avoid any
statistical bias due to the existence of population structure.
After excluding parent samples with missing genotypes
or unknown/affected T1D status, only 1,675 families
remained eligible for AFBAC.
The ﬁne mapping data include 2,957 SNPs in the MHC
genotyped on two oligonucleotide pool assays (OPA) using
the Illumina Golden Gate platform at the Wellcome Trust
Sanger Institute. HLA typing information is available for
eight loci: HLA-A,- B,- C,- DPA1,- DPB1,- DRB1,- DQA1
and -DQB1. Quality control on the SNP genotypes was
performed using PLINK (Purcell et al. 2007). First, any
Mendelian errors were set as missing. Then, SNPs with
call rate \0.95 and MAF\0.01 were discarded. The
remaining 2,338 SNPs were tested for HWE and those with
p\0.05/2338 & 2.14 9 10
-5 were removed, resulting in
a total of 2,259 SNPs. Information on access to data
and samples is available at http://www.t1dgc.org/views/
vw_access.cfm, and details of the dataset can be found in
(Brown et al. 2009).
Affected family-based controls
Families from the T1DGC dataset were converted into
cases and pseudo-controls using the AFBAC method
(Thomson 1995). Samples of any affected parents were
removed. In families with multiple children, all but the
child with the least missing genotypes were discarded. The
affected child became the case, and the two non-transmit-
ted haplotypes from the unaffected parents were merged
into a pseudo control. For the SNP genotypes, the AFBAC
procedure was done by Beagle v.3.0 (Browning and
Browning 2009), which at the same time performed hap-
lotype phase inference and imputation for missing values.
For the multiallelic HLA genotypes, AFBAC was imple-
mented using Matlab.
Phasing of multi-allelic HLA genotypes in trio families
In trio families, haplotype phases can be unambiguously
determined, except for the case when both parents and the
child are heterozygous for the same genotype, say AB.
With highly diversiﬁed HLA alleles, only about 1.8% of
the genotypes fall into that category. In those situations,
the phase can be inferred from the haplotypes of the
nearby HLA genes. In this work, we considered all HLA
genes within 1 Mb of the target whose phase was being
inferred. However, if there were fewer than two genes
within that distance, the closest two were picked, even
though they might be outside the range or both lie on the
same side of the target. Those nearby genes with directly
determined phases made up four known haplotypes: one
transmitted and one non-transmitted haplotype from each
parent. Based on the other known haplotypes in the
dataset, we had counts nAi, nBi of the number of A alleles
and B alleles, respectively, with haplotype i. A one-sided
p value was then obtained using the MH test statistics,
with each end of the p value in support of one of the two
possible solutions for phasing. The inferred phase was
adopted when the two-sided p value was \0.05. Other-
wise, the algorithm was run again with reference to one
fewer gene, excluding the most distant one ﬁrst. The
process was repeated until a two-sided p\0.05 was
reached using the greatest number of closest genes in
computing the statistics. If none of the gene combinations
could result in p\0.05, the solution supported by the
smallest p value was adopted. Overall, the phase could be
inferred at an average p value of 0.0034.
p value-based partitioning of HLA strata
The objective of the algorithm was to improve the statis-
tical power of stratiﬁed analysis by reducing the number of
HLA strata without compromising their confounding
effects in the conditional analysis. Each stratum consisted
of a set of genotypes Gi, where i = 1,…,n. We ﬁrst
selected the minimum set of Gi that gave a T1D association
with p\threshold, with preference given to primary fac-
tors HLA-DRB1 and -DQB1. In this work, we chose a
conservative threshold of 0.5 to ensure that even factors
with weak confounding effects are retained. Then, we
progressively grew the set of genotypes by including the
next one that shows the strongest additional association
with p\0.5. The process continued until there were no
more genotypes in the stratum that could further differen-
tiate the cases and controls with p\0.5. This effectively
eliminated any uninformative factors in a stratum. The
power of the conditional analysis was thus improved with
more samples per stratum. This approach also works for
haplotype strata.
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The method was used to test the T1D association of a
locus, an SNP in this case, conditional on the DR/DQ
haplotypes, the primary genetic factors of the disease. It is
an extension to the conditional haplotype method (CHM),
such that an overall p value across all DR/DQ haplotype
strata is obtained for each SNP by applying the MH test
statistic (Mantel and Haenszel 1959; Yu and Schaid 2007).
The only assumption of the statistic is the randomization of
subjects into the levels of the factor. Let there be m cases
and n controls for the DR/DQ haplotype stratum i. Suppose
N out of the (m ? n) haplotypes carry allele 1 at the test
SNP with x of them being controls. Then, variable x fol-
lows the hypergeometric distribution with mean and vari-
ance given by
l ¼
nN
m þ n
andr2 ¼
Nmnðn þ m   NÞ
ðn þ mÞ
2ðn þ m   1Þ
:
To test whether an SNP is associated with the disease
conditional on the primary haplotypes, statistics of
individual strata can be combined into one MH statistic
MH ¼
P
i ðxi   liÞ
   2
P
i r2
i
Under the null hypothesis that there is no association in
any stratum, the MH statistic has a v
2 distribution with one
degree of freedom. For the asymptotic distribution to hold,
it only requires the overall sample size be reasonably large.
Since the MH method is targeted at detecting average
effects across strata, it is a common method for assessing
average partial association. All haplotype counts were
determined using Matlab, and the conditional p values of
each SNP were calculated by the mantelhaen.test function
in R’s stats library.
Genotype-based CA trend test with stratiﬁcation
for conditional analysis
The CA trend test (Armitage 1955) is typically used in the
analysis of ordered categorical data and is a common
genotype-based test for association studies (Armitage
1955; Freidlin et al. 2002). For a biallelic marker with
alleles denoted by a and A, there are three possible geno-
types {aa, aA and AA} indexed by k = 0, 1, 2. The cate-
gories are ordered by an increasing number of allele A in
the genotypes. For each DR/DQ genotype i, let mk, nk be
the number of cases and controls of genotype k, and M,
N be the total number of cases and controls within the
stratum. Then, the CA statistic is given by
CA ¼
X
k tkðmkN   nkMÞ;
where tk are weights, and the expression can be viewed as
the sum of differences between the fraction of cases and
the fraction of controls across the genotype categories.
Under the null hypothesis that there is no association in
any category, the CA statistic is a zero-mean normal
distribution at large sample size. The choice of weights tk
for optimum statistical power is dependent on the type of
associations. For instance, the optimum t values for testing
whether allele A is dominant or recessive over allele a are
(0, 1, 1) and (1, 1, 0), respectively. In this study, we chose
t = (0, 1, 2), which is optimum for testing codominant or
additive inheritance and often used in genome-wide
association studies. The independence_test function in R’s
coin library was used to perform the trend tests with
stratiﬁcation by DR/DQ genotypes. Details of the con-
ceptual framework and implementation of the conditional
inference procedures can be found in (Hothorn et al.
2008).
Linkage disequilibrium analysis
The LD among the 22 replicated SNPs was analyzed using
Haploview v.4.1 (Barrett et al. 2005). The D0 and r
2
measure was generated for each SNP pair based on the
HapMap CEU haplotypes for data release #22, with a total
of 120 haplotypes of the northern and western European
ancestry. The dataset consists of three different ﬁles: data,
sample and legend, which can be downloaded from
http://hapmap.ncbi.nlm.nih.gov/downloads/phasing/2007-
08_rel22/phased/. Only SNPs under investigation were
extracted from the haplotype ﬁles for input to Haploview.
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